0001445866-16-002043.txt : 20160509 0001445866-16-002043.hdr.sgml : 20160509 20160509160522 ACCESSION NUMBER: 0001445866-16-002043 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160509 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160509 DATE AS OF CHANGE: 20160509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CANNASYS INC CENTRAL INDEX KEY: 0001417028 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 880367706 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-54476 FILM NUMBER: 161631653 BUSINESS ADDRESS: STREET 1: 1720 SOUTH BELLAIRE STREET STREET 2: SUITE 325 CITY: DENVER STATE: CO ZIP: 80222 BUSINESS PHONE: 800-420-4866 MAIL ADDRESS: STREET 1: 1720 SOUTH BELLAIRE STREET STREET 2: SUITE 325 CITY: DENVER STATE: CO ZIP: 80222 FORMER COMPANY: FORMER CONFORMED NAME: Thermal Tennis Inc. DATE OF NAME CHANGE: 20071031 8-K 1 cannasys8k05092016.htm 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):  May 9, 2016


CANNASYS, INC.
(Exact name of registrant as specified in its charter)
         
Nevada
  
000-54476
  
88-0367706
(State or other jurisdiction of
  
(Commission File Number)
  
(IRS Employer
incorporation or organization)
      
Identification No.)
         
1350 17th Street, Suite 150
    
Denver, Colorado
  
80202
(Address of principal executive offices)
  
(Zip code)
     
Registrant's telephone number, including area code:
  
Phone: (720) 420-1290
     
N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

1
EXPLANATORY NOTE

The information in this report, including the exhibit, is being furnished pursuant to Item 7.01 and Item 9.01 of Form 8-K and General Instruction B.2 thereunder.  Such information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.


ITEM 7.01—REGULATION FD DISCLOSURE

On May 9, 2016, CannaSys, Inc. issued a press release, a copy of which is attached as Exhibit 99.01.


ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS

The following is filed as an exhibit to this report:

Exhibit
Number
  
 
Title of Document
  
 
Location
         
99
  
Miscellaneous
    
99.01
  
Press release dated May 9, 2016
  
Attached


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
CANNASYS, INC.
   
     
     
Dated: May 9, 2016
By:
/s/ Michael A. Tew
   
Michael A. Tew, Chief Executive Officer


2
 EX-99.01 2 exhibit9901.htm EXHIBIT 99.01
Exhibit 99.01
 

CANNASYS, INC. ANNOUNCES LETTER OF INTENT TO ACQUIRE CITIZENTOKE FROM BETAKILLERS, LLC
DENVER, May 09, 2016 (GLOBE NEWSWIRE) -- CannaSys, Inc. (OTC QB:MJTK), a leading marketing, branding and technology company focused on the regulated cannabis industry, today announced it has signed a letter of intent to acquire CitizenToke, an innovative new deals communication platform for the cannabis industry, from BetaKillers, LLC, a Denver based innovation laboratory and development firm. Terms were not disclosed. 
CitizenToke, initially a mobile web based platform, will communicate deals and distribute coupons to cannabis consumers and patients through a unique text message based system. The system is designed not only to enhance consumer's retail experience but also provide incentive for consumers to download and redeem coupons in a timely manner. 
Ben Tyson, co-founder of BetaKillers, noted, "The launch of CitizenToke will disrupt the way in which consumers interact with retailers in the regulated cannabis industry. In partnership with CannaSys, we believe we can more effectively democratize the way consumers and patients receive timely, interactive deals from dispensaries."
BetaKillers, in partnership with CannaSys, is readying CitizenToke's launch into the market in partnership with several launch partners. As part of the transaction, BetaKillers' core team will work with CannaSys to launch and bring to market the CitizenToke product, including providing timely enhancements and ongoing marketing support. 
"We are excited to launch our new product partnership with BetaKillers, a sophisticated group of developers with a keen eye for the consumer," said Michael Tew, CEO of CannaSys. "We have big plans for CitizenToke. Leveraging our existing partnerships, we believe CitizenToke will completely turn upside down the way cannabis retailers communicate with consumers and we are looking forward to bringing it to market."
About CannaSys, Inc.
CannaSys is a leading technology solutions, marketing, and branding company in the regulated cannabis industry. Its core products are delivered "software as a service" to facilitate point-of-purchase transactions, customer relationship marketing solutions, and regulated cannabis laboratory information management systems. CannaSys plans to develop, acquire, and build strategic relationships with other businesses in order to bring additional solutions to market in both established and developing medical and recreational cannabis states. For more information, please visit www.cannasys.com.
About BetaKillers, LLC
Beta Killers is a full-service innovation laboratory focused on developing radical new approaches to business-to-consumer interactions. Through identifying and anticipating problems in today's rapidly-changing technology environment, BetaKillers innovates clever solutions based on three core principles: simplicity, functionality, and beauty. BetaKillers first wireframes these solutions, then fleshes them out to fully-functional, market-ready prototypes. Beta Killers innovates across a wide array of industries, with a particular focus on the cannabis industry. To learn more, please visit www.betakillers.com.
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of CannaSys's products, increased levels of competition for CannaSys, new products and technological changes, CannaSys's dependence on third-party suppliers, and other risks detailed from time to time in CannaSys's periodic reports filed with the Securities and Exchange Commission.
Contact:
CannaSys, Inc.
Michael A. Tew
Chief Executive Officer
Tel: 720.420.1290
Email: michael.tew@cannasys.com
Web: www.cannasys.com